Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 213
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending
Weekly Psychedelic Policy Briefing: Oct. 27, 2026
Pharma Moves In: Investors, Developers and Lilly’s Carole Ho at the Psychedelic Healthcare Forum
Mostly Supportive, Somewhat Divided: Stakeholders Respond to FDA’s Psychedelics Docket
New Study: LSD Makes Brain Rhythms Faster and Increases Neural Complexity
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022
Awakn Life Sciences Files Patent Application for a New Class of...
PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug...
Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical...
FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety...
Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in...
Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its...
Beckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for...
Psychedelic Bulletin: DEA Moves to Schedule 5 Tryptamines; Eleusis Unveils SPAC;...
Horizons: Grounds for Collective Effervescence
Load more